Subtopic Deep Dive
β-Lactam Cholesterol Absorption Inhibitors
Research Guide
What is β-Lactam Cholesterol Absorption Inhibitors?
β-Lactam cholesterol absorption inhibitors are 2-azetidinone derivatives structurally related to ezetimibe that selectively block intestinal NPC1L1-mediated cholesterol uptake to lower serum lipid levels.
These compounds mimic ezetimibe's β-lactam core with modifications like CF3 substitutions or amino groups to enhance potency and bioavailability (Liu et al., 2013; Dražić et al., 2014). Key syntheses employ cross-metathesis, 1,3-dipolar cycloadditions, and allylic amination for stereocontrol (Śnieżek et al., 2013; Humpl et al., 2016). Over 10 papers from 2008-2018 detail their design and evaluation, with foundational works exceeding 200 citations each (Mehta et al., 2010; Wang et al., 2012).
Why It Matters
β-Lactam inhibitors address hypercholesterolemia by reducing intestinal cholesterol absorption, complementing statins in cardiovascular therapy. Ezetimibe analogs with CF3 groups showed improved inhibition in biological assays (Liu et al., 2013). Amino-β-lactam derivatives reduced cholesterol uptake in cell models and mouse studies, offering leads for oral drugs (Dražić et al., 2014; Dražić et al., 2015). These advances support development of next-generation lipid-lowering agents amid rising cardiovascular disease rates.
Key Research Challenges
Stereoselective β-Lactam Synthesis
Achieving high diastereoselectivity in ezetimibe-like scaffolds remains difficult due to competing reaction pathways. Cross-metathesis and allylic amination provide control but require optimized ligands (Humpl et al., 2016; Wang et al., 2012). Scalable routes for clinical candidates are limited (Śnieżek et al., 2013).
Potency Optimization via Bioisosteres
Modifying ezetimibe with CF3 or amino groups improves binding but often reduces oral bioavailability. SAR studies identify hits yet struggle with NPC1L1 selectivity (Liu et al., 2013; Dražić et al., 2014). Balancing inhibition and pharmacokinetics challenges drug development.
Absolute Configuration Determination
Assigning stereochemistry in chiral 3-amino-β-lactams demands advanced spectroscopy. ECD and TDDFT methods resolve isomers but are computationally intensive (Dražić et al., 2016). This hinders evaluation of enantiopure inhibitors.
Essential Papers
Aromatic Spiroketal Bisphosphine Ligands: Palladium‐Catalyzed Asymmetric Allylic Amination of Racemic Morita–Baylis–Hillman Adducts
Xiaoming Wang, Fanye Meng, Yan Wang et al. · 2012 · Angewandte Chemie International Edition · 207 citations
Showing a backbone: The spiroketal backbone of the bis(phosphine) ligand 1 led to good regio- and enantioselectivity in the palladium-catalyzed asymmetric allylic amination of racemic Morita–Baylis...
2-Azetidinone – A new profile of various pharmacological activities
Parul Mehta, Narendra Pratap Singh Sengar, A Pathak · 2010 · European Journal of Medicinal Chemistry · 206 citations
Total Synthesis of Ezetimibe, a Cholesterol Absorption Inhibitor
Marcin Śnieżek, Sebastian Stecko, Irma Panfil et al. · 2013 · The Journal of Organic Chemistry · 52 citations
Ezetimibe (1), a strong β-lactamic cholesterol absorption inhibitor, was synthesized from (R)-6-(4-fluorophenyl)-5,6-dihydro-2H-pyran-2-one 7. Independent pathways were analyzed in order to select ...
Azetidines, Azetines and Azetes: Monocyclic
Girija S. Singh, Matthias D’hooghe, Norbert De Kimpe · 2008 · Elsevier eBooks · 42 citations
4-CF3-ezetimibe analogs: design, synthesis, and biological evaluation of cholesterol absorption inhibitions
Yingle Liu, Junling Chen, Gaihong Wang et al. · 2013 · Tetrahedron Letters · 21 citations
Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors
Tonko Dražić, Krešimir Molčanov, Vinay Sachdev et al. · 2014 · European Journal of Medicinal Chemistry · 21 citations
Stereoselective Synthesis of Ezetimibe via Cross-Metathesis of Homoallylalcohols and α-Methylidene-β-Lactams
Marek Humpl, Jiří Tauchman, Nikola Topolovčan et al. · 2016 · The Journal of Organic Chemistry · 19 citations
Ru-catalyzed cross-metathesis (CM) reaction between β-arylated α-methylidene-β-lactams and terminal olefins was developed. The CM reaction is effectively catalyzed with Hoveyda-Grubbs second-genera...
Reading Guide
Foundational Papers
Start with Mehta et al. (2010, 206 citations) for azetidinone pharmacology overview, then Śnieżek et al. (2013, 52 citations) for ezetimibe synthesis benchmark, and Wang et al. (2012, 207 citations) for asymmetric amination enabling scaffolds.
Recent Advances
Study Humpl et al. (2016, 19 citations) for cross-metathesis advances and Dražić et al. (2014/2015, 21/18 citations) for novel amino-β-lactam inhibitors with in vivo data.
Core Methods
Core techniques: Pd/spiroketal-catalyzed allylic amination (Wang et al., 2012), Hoveyda-Grubbs cross-metathesis (Humpl et al., 2016), 1,3-dipolar cycloaddition (Śnieżek et al., 2013), and ECD/TDDFT for stereochemistry (Dražić et al., 2016).
How PapersFlow Helps You Research β-Lactam Cholesterol Absorption Inhibitors
Discover & Search
Research Agent uses searchPapers('β-lactam ezetimibe analogs') to retrieve 10+ core papers like Śnieżek et al. (2013), then citationGraph maps asymmetric synthesis influences from Wang et al. (2012) with 207 citations. findSimilarPapers on Dražić et al. (2014) uncovers related amino-β-lactam SAR studies; exaSearch drills into NPC1L1 inhibition mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent to extract synthesis yields from Humpl et al. (2016), then verifyResponse with CoVe cross-checks stereoselectivity claims against Liu et al. (2013). runPythonAnalysis plots SAR data from Dražić et al. (2014) using pandas for IC50 trends, with GRADE scoring evidence strength on cholesterol uptake assays.
Synthesize & Write
Synthesis Agent detects gaps in stereoselective routes post-2016 via contradiction flagging across Śnieżek et al. (2013) and Humpl et al. (2016). Writing Agent uses latexEditText for reaction schemes, latexSyncCitations to integrate 10 papers, and latexCompile for a review manuscript; exportMermaid visualizes synthesis pathways as flowcharts.
Use Cases
"Plot IC50 values of amino-β-lactam cholesterol inhibitors from recent papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas plot of Dražić et al. 2014/2015 IC50 data) → matplotlib figure of potency trends.
"Write LaTeX section on ezetimibe synthesis variants with citations"
Research Agent → citationGraph(Śnieżek 2013) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(10 papers) + latexCompile → formatted section with schemes.
"Find GitHub repos implementing cross-metathesis for β-lactams"
Research Agent → searchPapers(Humpl 2016) → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → curated list of Hoveyda-Grubbs catalysis code.
Automated Workflows
Deep Research workflow scans 50+ β-lactam papers via searchPapers → citationGraph → structured report ranking ezetimibe syntheses by yield/stereoselectivity (Śnieżek et al., 2013 first). DeepScan's 7-step chain: readPaperContent(Humpl et al., 2016) → verifyResponse(CoVe on metathesis claims) → runPythonAnalysis(yield stats) → GRADE critique. Theorizer generates hypotheses on CF3 bioisosteres from Liu et al. (2013) + Dražić et al. (2014) SAR.
Frequently Asked Questions
What defines β-lactam cholesterol absorption inhibitors?
They are 2-azetidinone-based ezetimibe analogs that inhibit NPC1L1 cholesterol transport in the intestine, featuring p-fluorophenyl and modified sidechains (Śnieżek et al., 2013; Dražić et al., 2014).
What are key synthesis methods?
Methods include 1,3-dipolar cycloaddition (Śnieżek et al., 2013), Ru-catalyzed cross-metathesis (Humpl et al., 2016), and Pd-catalyzed allylic amination (Wang et al., 2012).
What are the most cited papers?
Top papers are Wang et al. (2012, 207 citations) on spiroketal ligands, Mehta et al. (2010, 206 citations) on azetidinone activities, and Śnieżek et al. (2013, 52 citations) on ezetimibe synthesis.
What open problems exist?
Challenges include scalable stereoselective syntheses, optimizing bioisosteres for dual potency/bioavailability, and absolute configuration assignments for 3-amino derivatives (Humpl et al., 2016; Dražić et al., 2016).
Research Synthesis of β-Lactam Compounds with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching β-Lactam Cholesterol Absorption Inhibitors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers
Part of the Synthesis of β-Lactam Compounds Research Guide